News Posts List
Background on the Reconciliation Process (PDF)
02/27/2010
From Patton-Boggs, LLP: In a recent interview, Senate Majority Leader Harry Reid (D-NV) opened the door to using the budget reconciliation process as a means to secure enactment of health care reform legislation, predicting that such legislation will be done in the next 60 days.
Autologous NK cell infusions in treatment resistant Cancer
02/27/2010
If you (or someone you know) has metastatic cancer of the lung, prostate, colon, rectum, kidney, pancreas or malignant melanoma that is not responding to standard treatments, you may be able to participate in our clinical trial designed to evaluate the safety of a new type of cell therapy. Specifically, we are testing the safety and tolerability of the infusion of a type of your own white blood cells called NK cells.
Bionomics BNC105 renal cancer trial commences in USA with Hoosier Oncology Group
02/26/2010
Trial Principal Investigator Dr Thomas E Hutson of the Baylor Sammons Cancer Centre/Texas Oncology commented The mechanism of action of BNC105 provides an innovative approach to the treatment of solid tumours, including metastatic renal carcinoma, by attacking established tumour vasculature. It is particularly exciting to be conducting a trial which has the potential of creating a new paradigm for the treatment of renal cancer.
Rexahn Pharmaceuticals' Kidney Cancer Drug
02/26/2010
Rexahn has yet to enroll a single patient in a phase II study of its experimental cancer drug Archexin in advanced kidney cancer. Rexahn announced the start of this Archexin study in May 2007! Since then, the number of patients enrolled equals zero -- as in zilch, nada.
Renal mass biopsies may help patients bypass surgery
02/26/2010
Using renal mass biopsy to guide treatment decisions for small tumors is cost-effective relative to direct surgery, and can spare many patients unnecessary surgical procedures, according to Massachusetts General Hospital researchers.
A.S. Aids Charitable Clubs
02/25/2010
According to board member Janelle Mungo, ATOs contract with Twiin stipulates that after the $16,500 the board funded is donated to the Kidney Cancer Association, 75 percent of ticket sales will be given to Twiin.
Informatics Careers Take Shape in Translational and Clinical Research
02/24/2010
There is no traditional training path into medical informatics, notes Eric Perakslis [director, Kidney Cancer Association], vice president for research and development informatics at Johnson & Johnson Pharmaceutical Research and Development L.L.C. in Titusville, New Jersey. In fact, if you talk to 10 people in medical informatics, you'll probably hear 10 different stories about how they got there. Physicians, nurses, pharmacists, and computer engineers all find their way into the field.
TV Show: Flash Back to Catch Up With FLASHFORWARD
02/24/2010
Dr. Bruce Varley: (Zachary Knighton) When the flash knocked everyone out, it stopped Bruce from committing suicide after hearing a diagnosis of stage four kidney cancer.
Forecasts for the Approval of Several More Angiogenesis Inhibitors Within the Next Five Years
02/24/2010
Several additional angiogenesis inhibitors are expected reach the market in the next five years. Compounds to watch include Pfizer's SU-11248, which has demonstrated efficacy in imatinib-resistant gastrointestinal stromal tumors; Bayer and Onyx Pharmaceuticals BAY-43-9006, which is in Phase III for renal cell carcinoma; and Genentech and Novartis's ranibizumab (Lucentis) for AMD.
Group looks to scale Mount Kilimanjaro for kidney cancer aid
02/23/2010
Jesse said that his dad fought the disease, but it was a difficult process to be a part of. Kidney cancer occurs roughly twice as often in males as in females, according to Kidney Cancer Association. Fifteen to 25 percent of patients have metastatic disease at the time of their diagnosis, meaning their cancer has spread to other areas of the body.
News Feed